|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3 Pt 1
|
|
pubmed:dateCreated |
2007-8-13
|
|
pubmed:abstractText |
While the incidence of lymph node positive prostate cancer has decreased during the prostate specific antigen era, the optimal treatment of these patients remains in question. We examined the impact of lymph node metastases on the outcome of patients following radical prostatectomy and investigated prognostic factors that affect survival.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0022-5347
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
178
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
864-70; discussion 870-1
|
|
pubmed:meshHeading |
pubmed-meshheading:17631342-Aged,
pubmed-meshheading:17631342-Disease Progression,
pubmed-meshheading:17631342-Disease-Free Survival,
pubmed-meshheading:17631342-Humans,
pubmed-meshheading:17631342-Lymph Node Excision,
pubmed-meshheading:17631342-Lymphatic Metastasis,
pubmed-meshheading:17631342-Male,
pubmed-meshheading:17631342-Middle Aged,
pubmed-meshheading:17631342-Neoplasm Recurrence, Local,
pubmed-meshheading:17631342-Prostate-Specific Antigen,
pubmed-meshheading:17631342-Prostatectomy,
pubmed-meshheading:17631342-Prostatic Neoplasms,
pubmed-meshheading:17631342-Risk Factors,
pubmed-meshheading:17631342-Survival Rate,
pubmed-meshheading:17631342-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.
|
|
pubmed:affiliation |
Department of Urology and Division of Biostatistics, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA.
|
|
pubmed:publicationType |
Journal Article
|
